Nesyrgy (Amlodipine Besilate, Nebivolol Hydrochloride)

Amlodipine besilate / nebivolol hydrochloride, the active ingredient in Nesyrgy, is a calcium channel blocker / beta‑blocker presented as a tablet for oral use. It is indicated for the treatment of hypertension in adult patients. GNH USA supplies Nesyrgy as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nesyrgy, a combination antihypertensive, is used to manage elevated blood pressure.

Hypertension: reduces systolic and diastolic blood pressure and helps achieve target blood pressure goals.

Common Side Effects: - Headache: mild to moderate intensity. - Peripheral edema: swelling of ankles or feet. - Flushing: transient warmth and redness. - Dizziness or light‑headedness. - Fatigue: general tiredness. - Nasal congestion: mild blockage.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure. - Bradycardia: abnormally slow heart rate. - Hepatic injury: elevated liver enzymes or jaundice. - Allergic reaction: rash, itching, or swelling. - Angioedema: rapid swelling of face, lips, or throat. - Cardiac conduction abnormalities: heart block or arrhythmia.

Before initiating therapy, consider the following precautions.

Monitor blood pressure: ensure adequate control and avoid excessive reduction. Assess cardiac function: evaluate heart rate and rhythm, especially in patients with conduction disorders. Review concomitant medications: watch for additive hypotensive effects. Use caution in hepatic impairment: dose adjustment may be required. Avoid abrupt discontinuation: taper gradually to prevent rebound hypertension. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nesyrgy may interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): increase amlodipine exposure. - CYP2D6 inhibitors (e.g., paroxetine): raise nebivolol plasma levels. - Other antihypertensives (e.g., ACE inhibitors, ARBs): additive blood‑pressure lowering effect.

Moderate Interactions (Monitor Closely):\n- Non‑dihydropyridine calcium‑channel blockers (e.g., verapamil): may enhance bradycardia. - Additional beta‑blockers: risk of excessive heart‑rate reduction. - Diuretics: may potentiate electrolyte disturbances. - NSAIDs: can blunt antihypertensive response. - Alcohol: may increase dizziness and hypotension.